# Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH)

Study · id `cardio:ct-nct03844594` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03844594](<https://clinicaltrials.gov/study/NCT03844594>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03844594

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 220 participants.

## Technical summary

Registry record NCT03844594. Allocation not applicable; no masking; primary purpose treatment. Start 2019-04-06 (actual); primary completion 2020-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 220 participants (planned count; ClinicalTrials.gov record NCT03844594, source copy `cardio:ctgov-nct03844594-2019-06-18`, retrieved 2026-10-26)
- Started: 2019-04-06 (actual) (ClinicalTrials.gov record NCT03844594, source copy `cardio:ctgov-nct03844594-2019-06-18`, retrieved 2026-10-26)
- Primary completion: 2020-06-30 (anticipated) (ClinicalTrials.gov record NCT03844594, source copy `cardio:ctgov-nct03844594-2019-06-18`, retrieved 2026-10-26)
- Completion: 2020-12-31 (anticipated) (ClinicalTrials.gov record NCT03844594, source copy `cardio:ctgov-nct03844594-2019-06-18`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03844594, source copy `cardio:ctgov-nct03844594-2019-06-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03844594-2019-06-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH)
- Condition: Acute Ischemic Stroke
- Intervention (Drug): Eptifibatide Injection
- Lead sponsor: Ministry of Science and Technology of the People´s Republic of China
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Ministry of Science and Technology of the People´s Republic of China (`cardio:org-ministry-of-science-and-technology-of-the-people-s-republic-dda658`)

## Provenance

Content hash: 3eee5c29417de8f1caba940513518826a137099d3647c11f03c038118f1b7198
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
